MyD88 is an adaptor protein for TLR4 signaling known to hyper-activate NF-κB, MAPK and PI3K pathways driving tumor survival and paclitaxel chemoresistance in EOC cells7, 8, 9, 10, 11. The gene discussed is MYD88; the disease is neoplasm.